10.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$9.74
Aprire:
$9.84
Volume 24 ore:
546.39K
Relative Volume:
1.08
Capitalizzazione di mercato:
$489.10M
Reddito:
$502.79M
Utile/perdita netta:
$23.71M
Rapporto P/E:
20.86
EPS:
0.5
Flusso di cassa netto:
$6.35M
1 W Prestazione:
-2.89%
1M Prestazione:
-18.90%
6M Prestazione:
-37.73%
1 anno Prestazione:
-47.93%
Core Laboratories Inc Stock (CLB) Company Profile
Nome
Core Laboratories Inc
Settore
Industria
Telefono
713-328-2673
Indirizzo
6316 WINDFERN ROAD, HOUSTON
Confronta CLB con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CLB
Core Laboratories Inc
|
10.43 | 456.75M | 502.79M | 23.71M | 6.35M | 0.50 |
![]()
SLB
Schlumberger Ltd
|
32.94 | 48.29B | 35.48B | 4.09B | 4.61B | 2.92 |
![]()
BKR
Baker Hughes Company
|
42.51 | 42.10B | 27.61B | 3.05B | 2.17B | 3.06 |
![]()
TS
Tenaris S A Adr
|
35.96 | 18.44B | 13.09B | 2.65B | 2.52B | 4.5936 |
![]()
HAL
Halliburton Co
|
20.97 | 17.48B | 22.56B | 2.10B | 2.34B | 2.39 |
![]()
FTI
Technipfmc Plc
|
35.12 | 14.37B | 9.27B | 827.80M | 1.24B | 1.90 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-12 | Aggiornamento | Citigroup | Sell → Neutral |
2023-06-30 | Downgrade | Citigroup | Neutral → Sell |
2023-04-18 | Downgrade | BofA Securities | Neutral → Underperform |
2023-01-09 | Aggiornamento | BofA Securities | Underperform → Neutral |
2022-10-07 | Aggiornamento | Citigroup | Sell → Neutral |
2022-09-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2022-04-18 | Downgrade | Piper Sandler | Neutral → Underweight |
2021-10-18 | Downgrade | BofA Securities | Neutral → Underperform |
2021-07-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2021-06-14 | Downgrade | Citigroup | Neutral → Sell |
2020-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
2020-11-11 | Reiterato | Cowen | Market Perform |
2020-10-13 | Aggiornamento | BofA Securities | Underperform → Neutral |
2020-09-29 | Aggiornamento | ABN Amro | Sell → Hold |
2020-07-16 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
2020-04-13 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
2020-03-09 | Downgrade | BofA/Merrill | Buy → Underperform |
2020-03-09 | Downgrade | Evercore ISI | Outperform → In-line |
2020-01-31 | Reiterato | Cowen | Market Perform |
2020-01-30 | Ripresa | Johnson Rice | Buy |
2020-01-14 | Iniziato | Bernstein | Mkt Perform |
2020-01-02 | Downgrade | Stifel | Buy → Hold |
2019-12-31 | Reiterato | Cowen | Market Perform |
2019-07-10 | Aggiornamento | BofA/Merrill | Neutral → Buy |
2019-02-25 | Aggiornamento | Tudor Pickering | Hold → Buy |
2018-12-19 | Downgrade | Credit Suisse | Outperform → Neutral |
2018-12-11 | Downgrade | JP Morgan | Overweight → Neutral |
2018-11-16 | Aggiornamento | Guggenheim | Neutral → Buy |
2018-11-01 | Aggiornamento | ABN Amro | Sell → Buy |
2018-10-29 | Reiterato | Cowen | Market Perform |
Mostra tutto
Core Laboratories Inc Borsa (CLB) Ultime notizie
Top chart patterns to watch in Core Laboratories Inc.Market Liquidity and Price Flow Analysis - Newser
Q4 EPS Estimates for Core Laboratories Cut by Zacks Research - MarketBeat
What analysts say about Core Laboratories Inc. stock outlookReal-Time Setup Summary with ROI Focus - Newser
Published on: 2025-08-12 00:31:29 - Newser
Can Core Laboratories Inc. rally from current levelsDaily Pick Forecast with Entry Zones - Newser
Will Core Laboratories Inc. bounce back from current supportFree Risk Controlled Short Term Trade Plans - Newser
Core Laboratories (CLB) Falls Amid a Difficult Time for the Oilfield Services Sector - MSN
Market reaction to Core Laboratories Inc.’s recent newsBuy Entry Confirmation Based on Technical Analysis - Newser
Is Core Laboratories Inc. building a consolidation baseFree Target Return Focused Trade Insights - Newser
When is the best time to buy Core Laboratories Inc. stockDaily Swing Candidate Analysis with Chart Patterns - Newser
What MACD signals say about Core Laboratories Inc.Market Forecast Summary Over Multi-Year Period - Newser
What’s next for Core Laboratories Inc. stockEarnings Season Playbook - mustnews.co.kr
What is Core Laboratories Inc. s debt to equity ratioFree Volume Spike Tracker - classian.co.kr
Why Core Laboratories Inc. is moving todayFree Capital Preserving Trade Plan Templates - Newser
Signal strength of Core Laboratories Inc. stock in tech scannersShort-Term Support and Resistance Forecast - Newser
Custom watchlist performance reports with Core Laboratories Inc.7-Day Equity Return Range Forecast Model - Newser
Reversal indicators forming on Core Laboratories Inc. stockFree Stock Selection With High Accuracy - Newser
Core Laboratories Dividend Details and Key Updates Before Ex-Dividend Date on Aug 4, 2025 - AInvest
How does Core Laboratories Inc. generate profit in a changing economyInvest smarter with actionable stock recommendations - Jammu Links News
When is Core Laboratories Inc. stock expected to show significant growthFree High-Return Strategy Alerts - Jammu Links News
How does Core Laboratories Inc. compare to its industry peersGet exclusive market insights for better trading - Jammu Links News
Is Core Laboratories Inc. stock overvalued or undervaluedGrow your wealth steadily and securely - Jammu Links News
Why is Core Laboratories Inc. stock attracting strong analyst attentionDiscover market opportunities with real-time data - Jammu Links News
How volatile is Core Laboratories Inc. stock compared to the marketNavigate the market with precision tools - Jammu Links News
What are the latest earnings results for Core Laboratories Inc.Get exclusive access to professional stock picks - Jammu Links News
Should I hold or sell Core Laboratories Inc. stock in 2025Market Forecast Signals For Fast Growth - Jammu Links News
Core Laboratories (NYSE:CLB) Shares Up 4.6%Still a Buy? - MarketBeat
Core Laboratories Inc. Breakout Confirmed by Volume MetricsAI Powered High Return Stock Calls Dominate Watchlists - metal.it
Here is Why Core Laboratories (CLB) Fell This Week - MSN
How many analysts rate Core Laboratories Inc. as a “Buy”Financial News Target Finder That Work - Jammu Links News
What recovery options are there for Core Laboratories Inc.Conservative Entry for High Return Setup Backed - metal.it
Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Core Laboratories (NYSE:CLB) Trading Down 6.5%Here's What Happened - MarketBeat
How Core Laboratories Inc. stock performs during market volatilityHigh Accuracy Alerts for ROI Traders Detected - metal.it
Does Core Laboratories Inc. stock pay reliable dividendsAI Powered High Return Stock Calls Dominate Watchlists - metal.it
Core Laboratories Inc. to Issue Quarterly Dividend of $0.01 (NYSE:CLB) - MarketBeat
What makes Core Laboratories Inc. stock price move sharplyConfirmed Setup With Expert Accuracy Supported - metal.it
Core Laboratories (NYSE:CLB) Shares Gap Up After Strong Earnings - MarketBeat
What is the dividend policy of Core Laboratories Inc. stockDynamic capital growth - jammulinksnews.com
What is Core Laboratories Inc. company’s growth strategyTremendous wealth creation - jammulinksnews.com
Core Laboratories outlines Q3 2025 revenue guidance of $127.5M-$134.5M amid margin improvements and global expansion - MSN
Moving Average Trends for Core Laboratories Inc. Stock: What They Indicate Weekly Breakout Forecast with Entry Zones - beatles.ru
Core Laboratories Inc Azioni (CLB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Core Laboratories Inc Azioni (CLB) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Teo Sow Hang | CAO & Treasurer |
Aug 01 '25 |
Option Exercise |
0.00 |
440 |
0 |
7,840 |
Teo Sow Hang | CAO & Treasurer |
May 01 '25 |
Option Exercise |
0.00 |
175 |
0 |
7,587 |
Tattoli Mark Damian | SVP, Gen Counsel & Secretary |
May 01 '25 |
Option Exercise |
0.00 |
450 |
0 |
16,243 |
Temeng Kwaku | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
25,528 |
Murray Katherine | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
21,221 |
Klingensmith Harvey Robert | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
41,962 |
Carnes Martha Z. | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
46,328 |
ANASTASIO CURT | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
15,736 |
Straughen Michael | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
29,186 |
Bruno Lawrence | Chairman and CEO |
Dec 31 '24 |
Option Exercise |
0.00 |
69,574 |
0 |
232,777 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):